HAEMATOLOGY
Anaemia and thrombosis in COVID patients
The global healthcare community recently came together to discuss the latest findings from the Coronavirus pandemic – through a new experience delivered entirely online, Omnia Health Live. COVID-19’s effect on haemoglobin and oxygen carrying capacity, as well as coagulation and thrombosis management, were among the many areas of investigation. Louise Frampton reports.
The Coronavirus pandemic dominated discussion at Omnia Health Live, with experts across the world sharing the latest findings on COVID-19 – from optimum management of patients, developments in diagnostics, and the impact of low quality PPE, to the key role of digital technologies and telehealth in keeping both patients and staff safe during these unprecedented times. Dr. Tedros, the Director-General at the
World Health Organization, gave a powerful address on the global impact of the ‘defining health crisis of our time’, pointing out that the COVID-19 pandemic has disrupted health systems, societies, businesses and economies. “The health sector has never been so
important. It is needed to save lives as well as support the global recovery. The pandemic has told us that health is not a luxury item, but a human right and the foundation of social and economic development. We have learned the hard way, that health is central to everything. In the future, the healthcare sector will play an important role in creating the healthier, safer, fairer world that we want. We should all be in this together,” he commented.
COVID-19 and anaemia The online event covered a wide range of
discussion areas including new insights into the incidence of anaemia and thrombosis among patients admitted to ICU. During the five-day, online event, Masimo hosted a webinar titled: ‘Haemoglobin, Coagulation & Oxygenation in COVID-19 Patients’. Featuring a panel of experts, topics for discussion included COVID-19’s effect on haemoglobin and oxygen carrying capacity,
Anaemia is a common finding in patients with a COVID-19 diagnosis. The pathology for anaemia will be variable, but hyperinflammation and anaemia of chronic disease is highly likely to be the underlying mechanism.
OCTOBER 2020
as well as insights into coagulation and thrombosis management. Dr. Mark Robinson, a consultant haematologist at Cambridge University, gave an insight into haemoglobin changes in patients with COVID-19. He explained that Addenbrooke’s Hospital have examined red blood cell concentration in COVID patients admitted to ICU, to establish whether these hospitalised patients are more likely to be anaemic. He reported that the majority of patients with the virus, presenting on ICU, demonstrated a degree of anaemia (on average, 100g per litre). “The nature of this anaemia is that it appears to be normocytic and normochromic, but what we don’t know is whether it is COVID itself that causes the anaemia or whether patients with anaemia are more likely to be hospitalised with
WWW.CLINICALSERVICESJOURNAL.COM l 81
▲
©ALEN THIEN
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
